Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis

Type Journal Article Author Karen H. Keddy Author Giovanni B. Migliori Author Martie Van Der Walt URL https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30413-7/abstract Series Comment Volume 8 Issue 11 Pages e1357-e1358 Publication The Lancet Global Health ISSN 2214-109X Date 00/11/2020 Extra Publisher: Elsevier PMID: 33069299 Journal Abbr The Lancet Global Health DOI 10.1016/S2214-109X(20)30413-7 Library Catalog www.thelancet.com Language English Abstract The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has gained the dubious honour as the single greatest infectious cause of global mortality in 2020. Active COVID-19 disease encompasses cough, fever, fatigue, and shortness of breath among other signs and symptoms.1,2 Risk factors for severe COVID-19 disease include diabetes, chronic obstructive pulmonary disease, immune suppression, and age. Short Title Developing health policies in patients presenting with SARS-CoV-2